This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Management of cardiogenic shock

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • seek expert help
  • admit to intensive care
  • pain relief e.g. diamorphine 5mg im/iv
  • anxiolytic e.g. prochlorperazine 12.5mg im/iv
  • 60% oxygen - later guided by blood gases
  • monitor: ECG; U+Es, blood gases; urine output via catheter; CVP; a 12 lead ECG is repeated every hour until a diagnosis is reached
  • correct arrhythmias
  • consider insertion of a Swan-Ganz catheter: the pulmonary wedge pressure should be maintained between 15-20 mmHg by a combination of fluid infusion, inotrope and vasodilator therapy (pulmonary oedema will develop if wedge pressure > 20 mmHg):
    • inotropes e.g. dobutamine (2.5-10 mcg/kg/min iv) in order to maintain a systolic blood pressure of > 80 mmHg
    • renal support e.g. dopamine (2-4 mcg/kg/min iv)
    • mechanical assistance may be given to the heart e.g. an intraaortic balloon pump

Additionally:

  • treat the underlying cause e.g. myocardial infarction
  • if new systolic murmur then may indicate development of VSD or papillary muscle rupture - early surgical repair is recommended - management of pulmonary oedema and hypotension as above
  • diuretics have no place in the acute management of cardiogenic shock - they may be used once the patient's cardiac output has improved (e.g. improved mental state and skin perfusion)

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.